The concept of “One Health” – which emphasizes the relationship between human, animal, plant and environmental health – has been gaining ground in scientific discussions in recent years.
Bristol Myers gets regulatory approval for anemia drug Reblozyl, secures FDA label expansion
Bristol Myers Squibb has scored another win for its anemia drug Reblozyl, revealing Monday evening the FDA granted the drug its third indication. The FDA
August 30, 2023